2019
DOI: 10.1016/j.ajem.2018.09.038
|View full text |Cite
|
Sign up to set email alerts
|

Assessment of proadrenomedullin as diagnostic or prognostic biomarker of acute appendicitis in children with acute abdominal pain

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
9
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(9 citation statements)
references
References 19 publications
0
9
0
Order By: Relevance
“…As prospective cohorts with abdominal pain in the ED tend to suffer from inclusion bias, because of a tendency to both focus on "acute abdomen" [25,26] and assess the performance of AP biomarkers [27], there are no comparable data on all-comer populations. Therefore, the question on the prevalence of extra abdominal causes of abdominal pain needs to be highlighted.…”
Section: Discussionmentioning
confidence: 99%
“…As prospective cohorts with abdominal pain in the ED tend to suffer from inclusion bias, because of a tendency to both focus on "acute abdomen" [25,26] and assess the performance of AP biomarkers [27], there are no comparable data on all-comer populations. Therefore, the question on the prevalence of extra abdominal causes of abdominal pain needs to be highlighted.…”
Section: Discussionmentioning
confidence: 99%
“…According to articles published on this topic, MR-proADM concentrations are higher in children with acute appendicitis than in children with non-specific abdominal pain [ 17 , 18 ]. Greater differences in the levels of this biomarker were seen in complicated cases than in uncomplicated cases of appendicitis, in the first study being not significant ( p = 0.159), probably due to the smaller number of patients, and being significant in the other ( p = 0.005).…”
Section: Resultsmentioning
confidence: 99%
“…A number of studies have taken nonspecific abdominal pain (NSAP) patients as CG into consideration. For instance, Oikonomopoulou et al [ 24 ] selected 185 non-AA cases as CG. The CG included NSAP (151, 81.6%), followed by mesenteric lymphadenitis (16, 8.6%), ileitis (4, 2.2%), acute gastroenteritis (5, 2.7%), pneumonia (2, 1.1%), streptococcal pharyngitis (1, 0.5%), influenza type B virus (1, 0.5%), constipation (1, 0.5%), and intussusception (1, 0.5%).…”
Section: Discussionmentioning
confidence: 99%